Plasma Hücre Antikorları

Plasma Hücre Antikorları AçıklamaDokümanlar Clonalpath™ and Clonalpath™-Plus have been designed for an optimal differentiation between monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) based on the percentage of immunophenotypically normal plasma cells. Pathological plasma cells can be differentiated from normal plasma cells according to their immunophenotypic pattern of expression of anti-CD19, CD56, CD45 and CD38. Clonalpath™ contains…

Read more

Lymphoclonal™-12

Lymphoclonal™-12 AçıklamaDokümanlar Lymphoclonal™-12 is a 12-color mixture for screening of B-cell lymphoma within a variety of clinical samples when the pre-test probability is low or unknown. This is particularly useful in paucicellular specimens such as fine needle aspirate, core biopsy, pleural, ascitic and cerebral spinal fluid (CSF) where limited sample is available. In comparison to the…

Read more

Lymphoclonal™-9

Lymphoclonal™-9 AçıklamaDokümanlar Lymphoclonal™-9 is a 6-color mixture designed to simultaneously determine, in peripheral blood, bone marrow and other body fluids, the major lymphocyte subpopulations including T-cells (CD3+), B-cells (CD19+ CD20+) and NK-cells (CD3- CD56+), as well as helper (CD3+ CD4+) and cytotoxic (CD3+ CD8+) T-cell subsets and B-cell subsets with light chain immunophenotype Kappa (CD19+ SmIgκ+)…

Read more

Lymphoclonal™

Lymphoclonal™ AçıklamaDokümanlar Lymphoclonal™ is a 4-color antibody mixture aimed to study lymphocyte subsets and determine clonality of B-cells in peripheral blood, bone marrow and other body fluids. Lymphoclonal™ is a rapid, effective and reliable combination for initial screening of lymphocyte subsets which permits the identification of total T-cells (CD3+), B-cells (CD19+) and NK-cells (CD3- CD56+) as well…

Read more

PNH Kit

PNH Kit AçıklamaDokümanlar Paroxysmal Nocturnal Haemoglobinuria (PNH) is an acquired hematopoietic stem-cell disorder related to the somatic mutation in PIG-A gene (X-chromosome). This genetic alteration results in partial or total deficiency of all proteins normally linked to the cell membrane by glycosylphosphatidyl-inositol (GPI). Flow cytometry provides an efficient diagnostic test in which the lack of GPI-anchored…

Read more

CD38 Multi-Epitope Reagent

CD38 Multi-Epitope Reagent AçıklamaDokümanlar Anti-CD38 monoclonal antibodies continue to demonstrate promising results as new treatments for patients with multiple myeloma. Therapeutic anti-CD38 targets this molecule, highly expressed on the surface of multiple myeloma cells, hampering its detection by flow cytometry. Cytognos has developed an anti-human CD38 multi-epitope reagent containing a mixture of antibodies that allows the identification…

Read more